Research Article

Therapeutic Use, Efficiency and Safety of the Proteolytic Pineapple Enzyme Bromelain-POS® in Children with Acute Sinusitis in Germany

J.M. BRAUN, B. SCHNEIDER and H.J. BEUTH
In Vivo March 2005, 19 (2) 417-421;

Article Information

vol. 19 no. 2 417-421
PMID 
15796206
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • October 2, 2004
  • December 9, 2004
  • Published online March 1, 2005.
Copyright & License 
Copyright © 2005 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. J.M. BRAUN1,
  2. B. SCHNEIDER2 and
  3. H.J. BEUTH3
  1. 1Institute of Immunology and Transfusion Medicine (IKIT), Interdisciplinary Centre of Clinical Research (IZKF), University of Leipzig,
    Johannisallee 30, 04103 Leipzig
  2. 2Institute of Biometry, University of Hanover,
    Carl-Neuberg-Str. 1, 30625 Hanover
  3. 3Institute of Naturopathy, University of Cologne,
    Robert-Koch-Str. 10, 50931 Cologne
    , Germany
  1. Correspondence to: H.J. Beuth, Institute of Naturopathy, University of Cologne, Robert-Koch-Str. 10, 50931 Cologne, Germany. Tel: 0221 4786414; Fax: 0221 4787017, e-mail: Josef.Beuth{at}medizin.uni-Koeln.de

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Therapeutic Use, Efficiency and Safety of the Proteolytic Pineapple Enzyme Bromelain-POS® in Children with Acute Sinusitis in Germany
J.M. BRAUN, B. SCHNEIDER, H.J. BEUTH
In Vivo Mar 2005, 19 (2) 417-421;
Twitter logo Facebook logo Mendeley logo

Jump to section

Related Articles

Cited By...

  • No citing articles found.